The synthetic production of survivin inhibitor AZTM, an azide-terminated survivin ligand derivative proposed by Abbott Laboratories, displays a significant cytotoxic effect on GBM cell lines, corresponding with cellular apoptotic characteristics [86]. The gene discussed is BIRC5; the disease is glioblastoma.